Concepedia

Yoshihito Shima

YS

Statistics

Publications

60

Citations

6.5K

H-Index

37

Active since

1993

Affiliations

The University of Osaka(Current)

Dana-Farber Cancer Institute

Osaka International University

The University of Tokyo

Harvard University

Yoshihito Shima is an author at The University of Osaka specializing in medicine, immunology, and autoimmune disease.

ORCID

Top concepts

Publications per year

1993–2023

60

Publications

60

Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy

Teru Hideshima, Dharminder Chauhan, Yoshihito Shima et al. · Blood · 2000 · 857 citations

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst et al. · The Lancet Respiratory Medicine · 2020 · 612 citations · Full text

, , +3

Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications

D. Gupta, SP Treon, Yoshihito Shima et al. · Leukemia · 2001 · 554 citations

, , +8

Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration

Klaus Podar, Yu‐Tzu Tai, Faith E. Davies et al. · Blood · 2001 · 417 citations

TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications

Constantine S. Mitsiades, Steven P. Treon, Nicholas Mitsiades et al. · Blood · 2001 · 390 citations · Full text

Rows per page

1–5 of 60